INT MEDICAL (01501) Proposes Full Circulation of H Shares

Stock News
2025/11/12

INT MEDICAL (01501) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H shares. According to the CSRC filing, the company has applied on behalf of certain shareholders to convert a total of 71.7866 million domestic shares held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (HKEX).

Upon obtaining all necessary filings and/or approvals from relevant regulatory authorities, including the CSRC and HKEX, and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and listed for trading on the Main Board of HKEX.

In accordance with the company's articles of association, no shareholders' meeting is required to approve the conversion and listing.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10